Clinical Mycology Today: Emerging Challenges and Opportunities.

Autor: Little J; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Rauseo AM; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Zuniga-Moya JC; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Spec A; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Pappas P; Division of Infectious Diseases, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA., Perfect J; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., McCarthy T; Division of Infectious Diseases, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA., Schwartz IS; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Jun 27; Vol. 11 (7), pp. ofae363. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).

Description of Cryptococcosis Following SARS-CoV-2 Infection: A Disease Survey Through the Mycosis Study Group Education and Research Consortium (MSG-19).

Autor: Walker J; University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama, USA., McCarty T; University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama, USA., McGwin G; University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama, USA., Ordaya EE; Mayo Clinic, Infectious Diseases, Rochester, Minnesota, USA., Vergidis P; Mayo Clinic, Infectious Diseases, Rochester, Minnesota, USA., Ostrosky-Zeichner L; University of Texas Health Sciences Center, Infectious Disease, Houston, Texas, USA., Mammadova M; University of Texas Health Sciences Center, Infectious Disease, Houston, Texas, USA., Spec A; Washington University, Division of Infectious Diseases, St Louis, Missouri, USA., Rauseo AM; Washington University, Division of Infectious Diseases, St Louis, Missouri, USA., Perfect J; Duke University, Infectious Diseases, Durham, North Carolina, USA., Messina J; Duke University, Infectious Diseases, Durham, North Carolina, USA., Vilchez G; University of Kentucky, College of Medicine, Lexington, Kentucky, USA., McMullen R; University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama, USA., Jones CT; The Ohio State University, College of Nursing, Columbus, Ohio, USA., Pappas PG; University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Feb 17; Vol. 78 (2), pp. 371-377.

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.

Autor: O'Halloran JA; Washington University St Louis, St Louis, Missouri., Ko ER; Duke University Health System, Durham, North Carolina., Anstrom KJ; University of North Carolina, Chapel Hill., Kedar E; St Lawrence Health, Potsdam, New York., McCarthy MW; Weill Cornell Medicine, New York, New York., Panettieri RA Jr; Robert Wood Johnson Medical School, New Brunswick, New Jersey., Maillo M; Sanatorio Diagnostico, Santa Fe, Argentina., Nunez PS; Hospital Nacional Hipolito Unanue, Lima, Peru., Lachiewicz AM; University of North Carolina, Chapel Hill., Gonzalez C; National Center for Advancing Translational Sciences, Bethesda, Maryland., Smith PB; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., de Tai SM; Hospital Central de la Fuerza Aerea del Peru, Lima, Peru., Khan A; Oregon Health and Science University, Portland., Lora AJM; University of Illinois at Chicago., Salathe M; University of Kansas Medical Center, Kansas City., Capo G; Trinitas Hospital, Elizabeth, New Jersey., Gonzalez DR; Nuevo Hospital Civil de Guadalajara Juan I. Menchaca, Guadalajara, Mexico., Patterson TF; University of Texas Health Science Center at San Antonio., Palma C; University of Rochester School of Medicine and Dentistry, Rochester, New York., Ariza H; Clinica Central SA, Villa Regina, Argentina., Lima MP; Hospital e Maternidade Celso Pierro-PUC Campinas, Campinas, Brazil., Blamoun J; MidMichigan Medical Center, Midland., Nannini EC; Sanatorio Britanico, Santa Fe, Argentina., Sprinz E; Hospital de Clinicas de Porto Alegre HCPA, Porto Alegre, Brazil., Mykietiuk A; Instituto Medico Platense, La Plata, Argentina., Alicic R; Providence Medical Research Center, Spokane, Washington., Rauseo AM; Washington University St Louis, St Louis, Missouri., Wolfe CR; Duke University Health System, Durham, North Carolina., Witting B; Weill Cornell Medicine, New York, New York., Wang JP; University of Massachusetts Medical Center, Worcester., Parra-Rodriguez L; Washington University St Louis, St Louis, Missouri., Der T; Duke University Health System, Durham, North Carolina., Willsey K; Weill Cornell Medicine, New York, New York., Wen J; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Silverstein A; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., O'Brien SM; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Al-Khalidi HR; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Maldonado MA; Bristol Myers Squibb, Philadelphia, Pennsylvania., Melsheimer R; Janssen Pharmaceuticals, Leiden, the Netherlands., Ferguson WG; AbbVie, Inc, North Chicago, Illinois., McNulty SE; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Zakroysky P; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Halabi S; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Benjamin DK Jr; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Butler S; Technical Resources International (TRI), Bethesda, Maryland., Atkinson JC; National Center for Advancing Translational Sciences, Bethesda, Maryland., Adam SJ; Foundation for the National Institutes of Health, Bethesda, Maryland., Chang S; National Center for Advancing Translational Sciences, Bethesda, Maryland., LaVange L; University of North Carolina, Chapel Hill., Proschan M; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland., Bozzette SA; National Center for Advancing Translational Sciences, Bethesda, Maryland., Powderly WG; Washington University St Louis, St Louis, Missouri.

Publikováno v: JAMA [JAMA] 2023 Jul 25; Vol. 330 (4), pp. 328-339.

The Geographic Distribution of Dimorphic Mycoses in the United States for the Modern Era.

Autor: Mazi PB; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA., Sahrmann JM; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA., Olsen MA; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA., Coler-Reilly A; Division of Bone and Mineral Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA., Rauseo AM; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA., Pullen M; Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Zuniga-Moya JC; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA., Powderly WG; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA., Spec A; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Apr 03; Vol. 76 (7), pp. 1295-1301.

The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma.

Autor: Kim JG; Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Zhang A; Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Rauseo AM; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Goss CW; Division of Biostatistics, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Mudd PA; Department of Emergency Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., O'Halloran JA; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Wang L; Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.

Publikováno v: Allergy [Allergy] 2022 Dec; Vol. 77 (12), pp. 3676-3679. Date of Electronic Publication: 2022 Jul 23.